Vivek P Chavda (Vivek Chavda)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 88

Top Topics

Clostridium Difficile

Respiratory Syndrome Coronavirus

Top Venues

Expert review of vaccines

Expert review of anti-infective therapy

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Vivek P Chavda, Pankti C Balar, Rajashri Bezbaruah, Dixa A Vaghela, Damanbhalang Rynjah, Bedanta Bhattacharjee, Vrashabh V Sugandhi, Ana Cláudia Paiva Santos
Nanoemulsions: Summary of a Decade of Research and Recent Advances. Nanomedicine (London, England) 19 (6) (2024)
Nimeet Desai, Vivek P Chavda, Thakur Raghu Raj Singh, Nanasaheb D Thorat, Lalitkumar K Vora
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives. Small (Weinheim an der Bergstrasse, Germany) (2024)
Vivek P Chavda, Pankti C Balar, Rajashri Bezbaruah, Dixa A Vaghela, Damanbhalang Rynjah, Bedanta Bhattacharjee, Vrashabh V Sugandhi, Ana Cláudia Paiva Santos
Nanoemulsions: Summary of a Decade of Research and Recent Advances. Nanomedicine (London, England) 19 (6) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy 22 (5) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy 22 (5) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy (2024)
Nimeet Desai, Vivek P Chavda, Thakur Raghu Raj Singh, Nanasaheb D Thorat, Lalitkumar K Vora
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives. Small (Weinheim an der Bergstrasse, Germany) 20 (35) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy (2024)
Vivek P Chavda, Pankti C Balar, Rajashri Bezbaruah, Dixa A Vaghela, Damanbhalang Rynjah, Bedanta Bhattacharjee, Vrashabh V Sugandhi, Ana Cláudia Paiva Santos
Nanoemulsions: summary of a decade of research and recent advances. Nanomedicine (London, England) (2024)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Nikita Sharma, Swati Punetha, Anand Sairam, Dixa Vaghela, Narges Dargahi, Vasso Apostolopoulos
Combatting infectious diarrhea: innovations in treatment and vaccination strategies. Expert review of vaccines 23 (1) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy 22 (5) (2024)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Nikita Sharma, Swati Punetha, Anand Sairam, Dixa Vaghela, Narges Dargahi, Vasso Apostolopoulos
Combatting infectious diarrhea: innovations in treatment and vaccination strategies. Expert review of vaccines 23 (1) (2024)
Avinash D Khadela, Vivek P Chavda, Humzah Postwala, Ramya Ephraim, Vasso Apostolopoulos, Yesha Shah
Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer. Cancers 15 (2) (2023)
Lalitkumar K Vora, Amol Dilip Gholap, Keshava Jetha, Thakur Raghu Raj Singh, Hetvi K Solanki, Vivek P Chavda
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics 15 (7) (2023)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity. Vaccines 11 (4) (2023)
Vivek P Chavda, Divya Teli, Pankti C Balar, Dixa Vaghela, Hetvi K Solanki, Akta Vaishnav, Lalitkumar K Vora
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population. Molecules (Basel, Switzerland) 28 (5) (2023)
Vivek P Chavda, Disha D Valu, Palak K Parikh, Nikita Tiwari, Abu Sufiyan Chhipa, Somanshi Shukla, Snehal S Patel, Pankti C Balar, Ana Cláudia Paiva Santos, Vandana Patravale
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants. Vaccines 11 (2) (2023)
Vivek P Chavda, Kajal P Baviskar, Dixa A Vaghela, Shilpa S Raut, Anjali P Bedse
Nasal sprays for treating COVID-19: a scientific note. Pharmacological reports : PR (2023)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity. Vaccines 11 (4) (2023)
Vivek P Chavda, Kajal P Baviskar, Dixa A Vaghela, Shilpa S Raut, Anjali P Bedse
Nasal sprays for treating COVID-19: a scientific note. Pharmacological reports : PR (2023)
Zoufang Huang, Vivek P Chavda, Rajashri Bezbaruah, Hemant Dhamne, Dong-Hua Yang, Hong-Bing Zhao
CAR T-Cell therapy for the management of mantle cell lymphoma. Molecular cancer 22 (1) (2023)
Divya Teli, Pankti Balar, Kishan Patel, Anu Sharma, Vivek P Chavda, Lalitkumar K Vora
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants. Metabolites 13 (2) (2023)
Vivek P Chavda, Pankti C Balar, Payal Dodiya, Joanna Bojarska
Nanocarrier-based delivery of peptides: challenges and way forward. Nanomedicine (London, England) (2023)
Vivek P Chavda, Rajashri Bezbaruah, Disha Valu, Bindra Patel, Anup Kumar, Sanjay Prasad, Bibhuti Bhusan Kakoti, Ajeet Kumar Kaushik, Mariya Jesawadawala
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. Vaccines 11 (2) (2023)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity. Vaccines 11 (4) (2023)
Ana Cláudia Paiva Santos, Tatiana Gonçalves, Diana Peixoto, Patrícia C Pires, K Velsankar, Niraj Kumar Jha, Vivek P Chavda, Imran Shair Mohammad, Letícia Caramori Cefali, Priscila Gava Mazzola, Filipa Mascarenhas-Melo, Francisco Veiga
Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems. Molecular pharmaceutics (2023)
Divya Teli, Pankti Balar, Kishan Patel, Anu Sharma, Vivek P Chavda, Lalitkumar K Vora
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants. Metabolites 13 (2) (2023)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity. Vaccines 11 (4) (2023)
Divya Teli, Pankti Balar, Kishan Patel, Anu Sharma, Vivek P Chavda, Lalitkumar K Vora
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants. Metabolites 13 (2) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Vivek P Chavda, Rajashri Bezbaruah, Disha Valu, Bindra Patel, Anup Kumar, Sanjay Prasad, Bibhuti Bhusan Kakoti, Ajeet Kumar Kaushik, Mariya Jesawadawala
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. Vaccines 11 (2) (2023)
Vivek P Chavda, Gargi Jogi, Srusti Dave, Bhoomika M Patel, Lakshmi Vineela Nalla, Krishna Koradia
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown! Vaccines 11 (3) (2023)
Avinash D Khadela, Vivek P Chavda, Humzah Postwala, Ramya Ephraim, Vasso Apostolopoulos, Yesha Shah
Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer. Cancers 15 (2) (2023)
Vivek P Chavda, Gargi Jogi, Srusti Dave, Bhoomika M Patel, Lakshmi Vineela Nalla, Krishna Koradia
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown! Vaccines 11 (3) (2023)
Vivek P Chavda, Vasso Apostolopoulos
Mosaic receptor binding domain nanoparticles: towards fourth-generation vaccination. Nanomedicine (London, England) (2023)
Vivek P Chavda, Toshika Mishra, Sathvika Kamaraj, Swati Punetha, Oishani Sengupta, Yash Joshi, Suneetha Vuppu, Dixa A Vaghela, Lalitkumar K Vora
Post-COVID-19 Fungal Infection in the Aged Population. Vaccines 11 (3) (2023)
Vivek P Chavda, Kajal P Baviskar, Dixa A Vaghela, Shilpa S Raut, Anjali P Bedse
Nasal sprays for treating COVID-19: a scientific note. Pharmacological reports : PR (2023)
Vivek P Chavda, Divya Teli, Pankti C Balar, Dixa Vaghela, Hetvi K Solanki, Akta Vaishnav, Lalitkumar K Vora
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population. Molecules (Basel, Switzerland) 28 (5) (2023)
Vivek P Chavda, Disha D Valu, Palak K Parikh, Nikita Tiwari, Abu Sufiyan Chhipa, Somanshi Shukla, Snehal S Patel, Pankti C Balar, Ana Cláudia Paiva Santos, Vandana Patravale
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants. Vaccines 11 (2) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Vivek P Chavda, Amit Z Chaudhari, Divya Teli, Pankti Balar, Lalitkumar K Vora
Propolis and Their Active Constituents for Chronic Diseases. Biomedicines 11 (2) (2023)
Zoufang Huang, Vivek P Chavda, Rajashri Bezbaruah, Hemant Dhamne, Dong-Hua Yang, Hong-Bing Zhao
CAR T-Cell therapy for the management of mantle cell lymphoma. Molecular cancer 22 (1) (2023)
Vivek P Chavda, Toshika Mishra, Sathvika Kamaraj, Swati Punetha, Oishani Sengupta, Yash Joshi, Suneetha Vuppu, Dixa A Vaghela, Lalitkumar K Vora
Post-COVID-19 Fungal Infection in the Aged Population. Vaccines 11 (3) (2023)
Vivek P Chavda, Divya Teli, Pankti C Balar, Dixa Vaghela, Hetvi K Solanki, Akta Vaishnav, Lalitkumar K Vora
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population. Molecules (Basel, Switzerland) 28 (5) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Vivek P Chavda, Vasso Apostolopoulos, Ranjit Sah
Langya henipavirus outbreak. Expert review of anti-infective therapy (2023)
Vivek P Chavda, Amit Z Chaudhari, Divya Teli, Pankti Balar, Lalitkumar K Vora
Propolis and Their Active Constituents for Chronic Diseases. Biomedicines 11 (2) (2023)
Divya Teli, Pankti Balar, Kishan Patel, Anu Sharma, Vivek P Chavda, Lalitkumar K Vora
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants. Metabolites 13 (2) (2023)
Vivek P Chavda, Amit Z Chaudhari, Divya Teli, Pankti Balar, Lalitkumar K Vora
Propolis and Their Active Constituents for Chronic Diseases. Biomedicines 11 (2) (2023)
Vivek P Chavda, Toshika Mishra, Suneetha Vuppu
Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2. Vaccines 11 (1) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Vivek P Chavda, Vasso Apostolopoulos
Global impact of delta plus variant and vaccination. Expert review of vaccines 21 (5) (2022)
Rajashri Bezbaruah, Vivek P Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee, Lalitkumar K Vora
Nanoparticle-Based Delivery Systems for Vaccines. Vaccines 10 (11) (2022)
Vivek P Chavda, Toshika Mishra, Suneetha Vuppu
Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2. Vaccines 11 (1) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Vivek P Chavda, Vasso Apostolopoulos
COVID-19 vaccine design and vaccination strategy for emerging variants. Expert review of vaccines 21 (10) (2022)
Vivek P Chavda, Shreya S Sonak, Nafesa K Munshi, Pooja N Dhamade
Pseudoscience and fraudulent products for COVID-19 management. Environmental science and pollution research international 29 (42) (2022)
Vivek P Chavda, Lalitkumar K Vora, Vasso Apostolopoulos
Monkeypox: a new face of outbreak. Expert review of vaccines 21 (11) (2022)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B Patel, Nikita Sharma, Zhe-Sheng Chen
Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacological reports : PR 74 (6) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu, Vasso Apostolopoulos
Reply to the letter ' Effectiveness of COVID-19 vaccines against Omicron variant' . Immunotherapy 14 (12) (2022)
Vivek P Chavda, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, Juti Rani Devi, Ratnali Bania, Vasso Apostolopoulos
Variant influenza: connecting the missing dots. Expert review of anti-infective therapy 20 (12) (2022)
Vivek P Chavda, Jinal Ajabiya, Divya Teli, Joanna Bojarska, Vasso Apostolopoulos
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules (Basel, Switzerland) 27 (13) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Vivek P Chavda, Yangmin Chen, Jayant Dave, Zhe-Sheng Chen, Subhash C Chauhan, Murali Mohan Yallapu, Vladimir N Uversky, Rajashri Bezbaruah, Sandip Patel, Vasso Apostolopoulos
COVID-19 and vaccination: myths vs science. Expert review of vaccines 21 (11) (2022)
Vivek P Chavda, Hetvi K Solanki, Majid Hassanzadeganroudsari, Vasso Apostolopoulos, Joanna Bojarska
Peptide-Drug Conjugates: A New Hope for Cancer Management. Molecules (Basel, Switzerland) 27 (21) (2022)
Vivek P Chavda, Elrashdy M Redwan
SARS-CoV-2: Immunopeptidomics and Other Immunological Studies. Vaccines 10 (11) (2022)
Vivek P Chavda, Melina Haritopoulou-Sinanidou, Rajashri Bezbaruah, Vasso Apostolopoulos
Vaccination efforts for Buruli ulcer. Expert review of vaccines 21 (10) (2022)
Vivek P Chavda, Aayushi B Patel, Darsh D Vaghasiya
SARS-CoV-2 variants and vulnerability at the global level. Journal of medical virology 94 (7) (2022)
Vivek P Chavda, Riddhi Prajapati, Disha Lathigara, Bhumi Nagar, Jay Kukadiya, Elrashdy Mustafa Redwan, Vladimir N Uversky, Mukesh N Kher, Rajvi Patel
Therapeutic monoclonal antibodies for COVID-19 management: an update. Expert opinion on biological therapy 22 (6) (2022)
Vivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu, Vasso Apostolopoulos
Therapeutics to tackle Omicron outbreak. Immunotherapy 14 (11) (2022)
Vivek P Chavda, Toshika Mishra, Suneetha Vuppu
Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2. Vaccines 11 (1) (2022)
Vivek P Chavda, Vasso Apostolopoulos
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? Vaccines 10 (3) (2022)
Vivek P Chavda, Toshika Mishra, Suneetha Vuppu
Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2. Vaccines 11 (1) (2022)
Vivek P Chavda, Disha R Vihol, Hetvi K Solanki, Vasso Apostolopoulos
The Vaccine World of COVID-19: India's Contribution. Vaccines 10 (11) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu, Vasso Apostolopoulos
A global picture: therapeutic perspectives for COVID-19. Immunotherapy 14 (5) (2022)
Vivek P Chavda, Rajashri Bezbaruah, Kangkan Deka, Lawandashisha Nongrang, Tutumoni Kalita
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far. Vaccines 10 (11) (2022)
Avinash Khadela, Vivek P Chavda, Humzah Postwala, Yesha Shah, Priya Mistry, Vasso Apostolopoulos
Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response. Vaccines 10 (10) (2022)
Vivek P Chavda, Disha Vihol, Bhavya Mehta, Dhruvil Shah, Manan Patel, Lalitkumar K Vora, Miguel Pereira-Silva, Ana Cláudia Paiva Santos
Phytochemical-loaded liposomes for anticancer therapy: an updated review. Nanomedicine (London, England) 17 (8) (2022)
Vivek P Chavda, Aayushi B Patel, Lalitkumar K Vora, Vasso Apostolopoulos, Bruce D Uhal
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert review of vaccines 21 (10) (2022)
Vivek P Chavda, Gargi Jogi, Ana Cláudia Paiva Santos, Ajeet Kumar Kaushik
Biodegradable and removable implants for controlled drug delivery and release application. Expert opinion on drug delivery 19 (10) (2022)
Vivek P Chavda, Anjali Pandya, Erica Kypreos, Vandana B Patravale, Vasso Apostolopoulos
Chlamydia trachomatis : quest for an eye-opening vaccine breakthrough. Expert review of vaccines 21 (6) (2022)
Vivek P Chavda, Anjali Pandya, Sreeranjini Pulakkat, Moinuddin Soniwala, Vandana B Patravale
Lymphatic filariasis vaccine development: neglected for how long? Expert review of vaccines (2021)
Vivek P Chavda, Radhika Pandya, Vasso Apostolopoulos
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era. Expert review of vaccines (2021)